Search

everythinglearnresearchcommunity

for

Search:↓

Connarus semidecandrus Jack extract promotes hair growth and thickness, reduces prostate cancer cell growth, and could potentially be used as a treatment for hair loss.

Understanding T cells and signaling pathways can lead to better treatments for hair loss.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

Hair loss in men may be caused by inflammation triggered by hormones, and treatments reducing inflammation could potentially promote hair growth.

Future treatments for hair loss may focus on personalized and regenerative approaches.

Female-pattern hair loss may involve an autoimmune-like process, suggesting new treatment options.

Alopecia treatments like 5α-reductase inhibitors and spironolactone are safe for breast cancer patients and high-risk women.

EX104 shows promise in treating hair loss by promoting hair growth and improving scalp health.

New hair regrowth therapies show promise but need more research.

Targeting SIRT1 with antisense oligonucleotides could be a promising treatment for hair loss.

Frontal fibrosing alopecia is a challenging hair loss condition with no known cause or definitive treatment.

Personalized medicine in dermatology uses molecular biomarkers to improve diagnosis and treatment but needs further advancements for practical use.

Protein tyrosine kinases are key in male pattern baldness, affecting skin structure, hair growth, and immune responses.

Women's hair loss can be due to hormonal changes and various conditions, with treatments focusing on stopping progression and managing symptoms.

The herbal mixture could potentially improve hair loss.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

Plant-based compounds may offer safer prostate cancer treatment with fewer side effects.

Alopecia and acne in women are complex conditions needing coordinated care and personalized treatment.

There is no standardized treatment for hidradenitis suppurativa, and individualized plans are needed.

Minoxidil and Finasteride are effective for male baldness; more research is needed for hair aging treatments.

Epitestosterone may counteract testosterone's effects and has roles in body processes like prostate growth and hair distribution.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

Minoxidil 2% and 5% are common treatments for female pattern hair loss, with other options including anti-androgens, oral contraceptives, and hair transplantation.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

Targeting DKK3–CKAP4 can help reverse hair loss in androgenetic alopecia.

Biological factors are crucial for developing new hair restoration treatments.

High levels of male hormones and irregular periods best predict how well PCOS patients will respond to metformin treatment.